Call Now Open
2026 Oxford-Harrington Rare Disease Scholar Award

Siegfried Reich, PhD has extensive senior executive leadership in the pharmaceutical industry and drug discovery field, with over 30 years of experience in medicinal chemistry.
Former Executive Vice-President of Research and CSO, Turning Point Therapeutics
Co-Founder and Former Senior Vice-President of Research, eFFECTOR Therapeutics
Former Vice-President and Head of Drug Discovery, SGX Pharmaceuticals